Drug Affordability in Practice: Who Saves, Who Pays, and What Happens to Access?
October 14, 2026 • 12:00pm Eastern
Register NowPrescription drug affordability policies are increasingly shaping how states, public programs, health plans, and other payers approach medication costs, impacting access and affordability downstream across public and private coverage.
Join HealthHIV and its partners—AiArthritis, the Partnership to Improve Patient Care (PIPC), the Partnership for Safe Medicines, and the Rare Access Action Project (RAAP)—for a live webinar that will examine where savings are anticipated to occur, who likely benefits, and how payment decisions can impact: coverage, reimbursement, benefit design, provider and pharmacy practices, patient assistance programs, and out-of-pocket costs.
The discussion will cover:
- State Prescription Drug Affordability Board (PDAB) and Council activities and Upper Payment Limits (UPLs) in states with that authority
- Medicaid Pharmacy & Therapeutics (P&T) Committees and Drug Utilization Review (DUR) processes—and other broader payer and utilization-management decisions
- Federal Drug Pricing Policy and Medicare Maximum Fair Price (MFP) under the Inflation Reduction Act (IRA)
Other Related Trainings
Addressing HIV and Overall Care Needs and Coordination Among Older Gay and Bisexual Men
Join Aniruddha Hazra, MD, as he examines the intersection of aging, HIV, and broader health needs for older gay and bisexual men, with a focus on care coordination and long-term wellness. Additionally, Dr. Hazra will also provide critical insights into managing comorbidities, addressing social and mental health challenges, and strengthening interdisciplinary approaches to ensure holistic, affirming care for aging gay and bisexual men living with or at risk for HIV.
Operationalizing Lenacapavir for PrEP in Your Health System: From Business Planning and Reimbursement to Pharmacy Readiness
As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access.
